DailyDoctor Archive Specialties Get app
All infectious diseases briefings

The edition · Infectious Diseases

MIC-based susceptibility testing is dependable for the drugs that decide a regimen

Pooled across 1,728 isolates, Sensititre MYCOTB matched reference testing closely for rifampicin and isoniazid and poorly for cycloserine. Plus what modelling says about ring versus community vaccination in a Bundibugyo outbreak, thirty-five years of HIV-1 subtype distribution, and why adjunctive steroids in herpes encephalitis remain unsupported.

The edition in brief

A meta-analysis of 14 studies and 1,728 isolates assessed the Sensititre MYCOTB broth microdilution plate against reference drug susceptibility testing for multidrug-resistant and pre-extensively drug-resistant tuberculosis. Sensitivity and specificity were high and consistent for rifampicin and isoniazid, specificity exceeded 0.98 for amikacin, kanamycin and ofloxacin, and performance was moderate for ethambutol, streptomycin, ethionamide and rifabutin. Cycloserine performed poorly, with pooled sensitivity of 0.436 even after sensitivity analysis. A stochastic network model calibrated to 2026 Bundibugyo virus outbreak data in the Democratic Republic of the Congo found that improving case detection and contact tracing alone cut expected mortality by 81.6%; adding reactive ring vaccination with a hypothetical 45%-effective vaccine added 10.5 percentage points, while community vaccination at 80% coverage reduced mortality by 86.6% at a cost of up to 111 doses per death averted. A systematic review and global survey covering 1,395,222 HIV-1 samples from 154 countries found subtype C responsible for 48.7% of infections worldwide in 2020-24, with distributions regionally distinct and broadly stable since 2000. A meta-analysis of four comparative studies and 209 patients found no evidence that adjunctive corticosteroids improve outcome in herpes simplex virus encephalitis, with all randomised estimates imprecise and compatible with benefit or harm.

In this edition
01
Clinical update

Where MIC-based tuberculosis susceptibility testing can be trusted

MIC-based testing with this platform is reliable for rifampicin, isoniazid and the injectables, but a susceptible cycloserine result should not be used to build a regimen.

2 min · Journal of clinical microbiologyRead →
Primary outcome
pooled sensitivity and specificity of Sensititre MYCOTB by drug
Effect
rifampicin sensitivity 0.976 (0.94-0.99), specificity 0.958; isoniazid 0.977 (0.95-0.99) and 0.957; cycloserine sensitivity 0.436 (0.190-0.725); moxifloxacin 0.801 (0.585-0.924)
02Research

In a filovirus outbreak, tracing beats vaccinating

Modelling a Bundibugyo outbreak put strengthened case finding and contact tracing ahead of vaccination, with ring vaccination adding only about ten percentage points once operations were strong.

2 min · The Lancet. Infectious diseasesRead →
03Research

Subtype C is half of global HIV, and the map has not moved much

Subtype C causes about half of HIV-1 infections worldwide and dominates in south Asia, which is a reason to interpret assays validated on subtype B with some caution.

2 min · The Lancet. Infectious diseasesRead →
04Pearl

Start aciclovir before the scan, not after the result

Start aciclovir the moment herpes encephalitis is considered, and do not let a normal early scan or a negative early PCR stop it.

1 minRead →
05Practice changer

Adjunctive steroids in herpes encephalitis: still no evidence to act on

Routine adjunctive corticosteroids in herpes simplex encephalitis have no supporting evidence, and the imprecision of the trials means benefit and harm both remain possible.

2 min · Journal of neurologyRead →

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this one is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

Tomorrow morning, before your first patient

One edition a day for infectious diseases, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free